{"id":380504,"date":"2020-11-12T17:57:10","date_gmt":"2020-11-12T22:57:10","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=380504"},"modified":"2020-11-12T17:57:10","modified_gmt":"2020-11-12T22:57:10","slug":"gohealth-inc-class-action-alert-wolf-haldenstein-adler-freeman-herz-llp-reminds-investors-that-it-has-filed-a-securities-class-action-lawsuit-in-the-united-states-district-court-for","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/gohealth-inc-class-action-alert-wolf-haldenstein-adler-freeman-herz-llp-reminds-investors-that-it-has-filed-a-securities-class-action-lawsuit-in-the-united-states-district-court-for\/","title":{"rendered":"GOHEALTH, INC. CLASS ACTION ALERT: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that it has filed a securities class action lawsuit in the United States District Court for the Northern District of Illinois against GoHealth, Inc."},"content":{"rendered":"
\n

APPROACHING LEAD PLAINTIFF DEADLINE ON NOVEMBER 20, 2020<\/h2>\n

PR Newswire<\/p>\n<\/p><\/div>\n

\n

\n \u00a0<\/b>
\n NEW YORK<\/span> and CHICAGO<\/span>, Nov. 12, 2020<\/span> \/PRNewswire\/ —\u00a0Wolf Haldenstein Adler Freeman<\/span> & Herz LLP <\/a>\u00a0reminds investors that \u00a0it has filed a \u00a0federal \u00a0securities \u00a0class \u00a0action \u00a0lawsuit \u00a0against GoHealth, Inc. \u00a0(“GoHealth” or the “Company”) (NASDAQ: GOCO).\u00a0\u00a0 The class action, filed in United States<\/span> District Court for the Northern District of Illinois<\/span>, Eastern Division, and docketed under 1:20-cv-05765, is on behalf of a class consisting of all persons other than Defendants who purchased or otherwise acquired GoHealth Class A common stock pursuant and\/or traceable to the registration statement issued in connection with GoHealth’s July 2020<\/span> initial public offering (the “IPO”). Wolf Haldenstein<\/span><\/a> is seeking to pursue remedies under the Securities Act of 1933 (the “Securities Act”) against GoHealth, certain of GoHealth’s officers and directors, and the private equity sponsor of the IPO and its affiliates.<\/p>\n

\n

\n
\n \"(PRNewsfoto\/Wolf
\n <\/a>\n <\/p>\n<\/p><\/div>\n

\n All <\/b>
\n \u00a0investors who purchased shares of<\/b>
\n GoHealth<\/b>
\n and incurred losses are urged<\/b>
\n to contact the firm immediately at \u00a0classmember@whafh.com<\/a> or (800) 575-0735 or (212) 545-4774. You may obtain additional information concerning the action or join the case<\/a> on our website, www.whafh.com.<\/a><\/b>\n <\/p>\n

If you \u00a0have \u00a0incurred \u00a0losses \u00a0in \u00a0the \u00a0shares of against \u00a0GoHealth.<\/b>,<\/b>you<\/b> may,<\/b>no later than November 20, 2020<\/span><\/b>, \u00a0<\/b>request that the Court appoint you lead plaintiff of the proposed class.\u00a0 Please contact Wolf Haldenstein<\/span><\/a> to learn more about your rights as an investor in the shares of GoHealth.<\/b><\/p>\n

\n
\n CLICK HERE TO JOIN CASE<\/a>
\n <\/b>\n <\/p>\n

On June 19, 2020<\/span>, GoHealth filed a registration statement\u00a0 with the United States Securities and Exchange Commission (“SEC”) for the IPO on Form S-1 (the “Registration Statement”), which was used to sell to the investing public 43.5 million shares of GoHealth Class A common stock at $21<\/span> per share, for total gross proceeds of $913.5 million<\/span>.<\/p>\n

Our complaint alleges that the Offering Materials for the IPO were negligently prepared and, as a result, contained untrue statements of material fact, omitted material facts necessary to make the statements contained therein not misleading, and failed to make necessary disclosures required under the rules and regulations governing their preparation. Specifically, the Offering Materials failed to disclose that at the time of the IPO:<\/p>\n